Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Microsoft
MSFT
|
+$633M |
| 3 |
Alibaba
BABA
|
+$501M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$484M |
| 5 |
Apple
AAPL
|
+$456M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$622M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$597M |
| 3 |
Comcast
CMCSA
|
+$461M |
| 4 |
UnitedHealth
UNH
|
+$409M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$343M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.08% |
| 2 | Consumer Discretionary | 2.25% |
| 3 | Financials | 2.23% |
| 4 | Healthcare | 2.22% |
| 5 | Industrials | 1.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
PUT
Stanley Black & Decker
SWK
$15.4B
| $13.6M | ﹤0.01% |
77,500
-27,500
| -26% | -$5.36M |
|
2502
PUT
Bio-Rad Laboratories Class A
BIO
$9.53B
| $13.6M | ﹤0.01% |
18,200
-36,500
| -67% | -$27.3M |
|
2503
CALL
Intellia Therapeutics
NTLA
$1.67B
| $13.6M | ﹤0.01% |
101,200
-107,800
| -52% | -$16.3M |
|
2504
CALL
Signet Jewelers
SIG
$3.52B
| $13.6M | ﹤0.01% |
171,900
-26,600
| -13% | -$1.95M |
|
|
GOOS
2505
PUT
Canada Goose Holdings
GOOS
$854M
| $13.6M | ﹤0.01% |
380,500
+91,400
| +32% | +$3.64M |
|
2506
Power Integrations
POWI
$3.51B
| $13.6M | ﹤0.01% |
137,001
+44,375
| +48% | +$4.3M |
|
2507
Organon & Co
OGN
$3.6B
| $13.6M | ﹤0.01% |
413,498
+359,938
| +672% | +$11.5M |
|
|
2508
CALL
Organon & Co
OGN
$3.6B
| $13.5M | ﹤0.01% |
412,420
+187,800
| +84% | +$6.01M |
|
|
FOXO
2509
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
| $13.5M | ﹤0.01% |
6,892
-821
| -11% | -$1.6M |
|
|
WLL
2510
PUT
DELISTED
Whiting Petroleum Corporation
WLL
| $13.5M | ﹤0.01% |
230,913
+110,913
| +92% | +$5.49M |
|
|
COOL
2511
DELISTED
Corner Growth Acquisition Corp. Class A Ordinary Shares
COOL
| $13.5M | ﹤0.01% |
1,378,738
+345,338
| +33% | +$3.36M |
|
2512
CALL
State Street Communication Services Select Sector SPDR ETF
XLC
$22.9B
| $13.4M | ﹤0.01% |
167,800
+15,000
| +10% | +$1.24M |
|
2513
PUT
Franco-Nevada
FNV
$45.2B
| $13.4M | ﹤0.01% |
103,300
-35,400
| -26% | -$5.19M |
|
|
LTHM
2514
DELISTED
Livent Corporation
LTHM
| $13.4M | ﹤0.01% |
579,990
-1,820,038
| -76% | -$40.8M |
|
2515
CALL
Willis Towers Watson
WTW
$30.8B
| $13.4M | ﹤0.01% |
+57,600
| New | +$12.8M |
|
|
NVO
2516
PUT
Novo Nordisk
NVO
$201B
| $13.4M | ﹤0.01% |
278,400
+68,400
| +33% | +$3.31M |
|
|
CS
2517
CALL
DELISTED
Credit Suisse Group
CS
| $13.4M | ﹤0.01% |
1,354,400
+134,300
| +11% | +$1.37M |
|
2518
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.66B
| $13.3M | ﹤0.01% |
+633,564
| New | +$12.7M |
|
|
FITB
2519
CALL
Fifth Third Bancorp
FITB
$52.7B
| $13.3M | ﹤0.01% |
314,200
+30,400
| +11% | +$1.16M |
|
2520
TripAdvisor
TRIP
$1.26B
| $13.3M | ﹤0.01% |
393,807
-1,118,027
| -74% | -$40.1M |
|
2521
PUT
British American Tobacco
BTI
$123B
| $13.3M | ﹤0.01% |
376,100
+239,400
| +175% | +$8.99M |
|
2522
Halliburton
HAL
$28.7B
| $13.3M | ﹤0.01% |
613,713
+239,561
| +64% | +$4.91M |
|
2523
BellRing Brands
BRBR
$1.25B
| $13.3M | ﹤0.01% |
431,414
+292,885
| +211% | +$9.38M |
|
|
HZAC
2524
DELISTED
Horizon Acquisition Corporation
HZAC
| $13.3M | ﹤0.01% |
1,329,152
-170,097
| -11% | -$1.69M |
|
2525
CALL
Teradyne
TER
$65.5B
| $13.3M | ﹤0.01% |
121,500
-36,800
| -23% | -$4.47M |
|
Similar funds
Ken Griffin's Q3 2021 Portfolio in Review
As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.
- Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
- Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
- Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
- Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
- Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
- Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
- Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.
Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.